BioSpace News Archive

Centene Corporation announced it will present at the Bank of America Merrill Lynch 2018 Health Care Conference, to be held May 15-17, 2018, at Encore at the Wynn in Las Vegas.

Heska Corporation announced that Kevin Wilson, Heska’s President & Chief Executive Officer will be presenting at the following upcoming conferences in May and June 2018.

Kush Bottles, Inc. announced it has completed its acquisition of Summit Innovations, LLC.

Forty Seven, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted two Fast Track designations to its lead candidate, 5F9, for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL).

The American Journal of Roentgenology recently published findings on statistical methods for downgrading the risk classification of breast masses to reduce the need for unnecessary breast biopsies.

The first data from two Phase 3 studies of the investigational compound esketamine nasal spray in patients with treatment-resistant depression are among 17 abstracts from the Janssen Pharmaceutical Companies of Johnson & Johnson to be presented at the American Psychiatric Association (APA) Annual Meeting.

Protagonist Therapeutics, Inc. announced that preclinical research findings on the Company’s selective dual mu/delta opioid receptor agonists have been accepted for oral presentation on Saturday, June 2, 2018 at the Digestive Diseases Week® (DDW) conference.

C4 Therapeutics (C4T) today announced that Andrew Phillips, Ph.D. has been appointed as President and Chief Executive Officer. Dr. Phillips has been leading C4T’s scientific efforts as Chief Scientific Officer since January 2016 and assumed corporate leadership responsibilities with his added appointment as President in September 2016

Catabasis Pharmaceuticals, Inc. will report first quarter 2018 financial results before the NASDAQ Global Market open on Thursday, May 10, 2018.

Charles River Laboratories International, Inc. announced an extension of its long-standing collaboration with The Michael J. Fox Foundation for Parkinson’s Research.